# Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World’s First Phase III Trial of a Generative AI-Driven Innovative Drug - insilico.com

*Источник: insilico.com*
*Дата: 2026-09-10*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOZGYxaEJhdjZOSXRvMWlfbXcwM18zRnVQeEplRldFci16U2stSUpIejkxOG5MWGxyMXJMU3lZYlVYWWF1UGE4Q05pVHRoVjdUUVVrMHhqUG1ORFFXSjJmdjlNNVhIRlFhczhYa0hrOVVrSU5PbFF6MlQ1NWNMeWd6V29Ba245cTV1Rnh0c2tNRS1CZw?oc=5" target="_blank">Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World’s First Phase III Trial of a Generative AI-Driven Innovative Drug</a>&nbsp;&nbsp;<font color="#6f6f6f">insilico.com</font>

[Оригинал](https://insilico.com/news/isn1009261-insilico-medicine-doses-first-patient-genesis-ipf-3)